Social networks
49 1 4,016 4,016Activities
Technologies
Entity types
Location
London, UK
London
United Kingdom
Employees
Scale: 2-10
Estimated: 16
Engaged corporates
3Added in Motherbase
3 years, 6 months agoDeveloping a new class of ADCs based on NMT inhibition to treat cancer
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
GSK Pharmaceutical, Pharmaceutical Manufacturing | GSK Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Sep 2024 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Oct 2023 | | |
Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Capitalistic Partnership Not event 19 Feb 2021 21 Nov 2024 | | |